RecallRadar

FDA Drug recall D-1128-2018

0.9% Sodium Chloride Injection USP 100 mL bags, Rx only, Baxter Healthcare Corporation Deerfield, IL 60015 USA, NDC 0338-0049-18

On 2018-09-05 the FDA classified a Class II recall of 0.9% Sodium Chloride Injection USP 100 mL bags, Rx only, Baxter Healthcare Corporation Deerfield, IL 60015 USA, NDC 0338-0049-18 by Baxter Healthcare, citing CGMP Deviations.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1128-2018
ClassificationClass II
Statusterminated
Initiated2018-08-21
Published2018-09-05
Last updated2026-09-13 11:52 UTC
CompanyBaxter Healthcare
DistributionMS, TX

Product

0.9% Sodium Chloride Injection USP 100 mL bags, Rx only, Baxter Healthcare Corporation Deerfield, IL 60015 USA, NDC 0338-0049-18

Reason

CGMP Deviations

Identifiers

ndc0338-0049-01
ndc0338-0049-02
ndc0338-0049-03
ndc0338-0049-04
ndc0338-0049-10
ndc0338-0049-41
ndc0338-0049-11
ndc0338-0049-31
ndc0338-0049-48
ndc0338-0049-18
ndc0338-0049-38
ndc0338-0043-03
ndc0338-0043-04
code_infoLot #: P380287, Exp. date 12/2019

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1128-2018%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.